{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:29:42Z","timestamp":1780399782216,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4232,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1111\/j.0022-202x.2004.22504.x","type":"journal-article","created":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T14:19:11Z","timestamp":1083939551000},"page":"1091-1095","source":"Crossref","is-referenced-by-count":82,"title":["Mortality Rate of Bullous Pemphigoid in a US Medical Center"],"prefix":"10.1016","volume":"122","author":[{"given":"Rand L.","family":"Colbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mjd.2001.116337","article-title":"Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.1977.01640080045002","article-title":"Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy","volume":"113","author":"Ahmed","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0020","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0025","first-page":"1","article-title":"Deaths: Preliminary data for 2001","volume":"51","author":"Arias","year":"2003","journal-title":"Natl Vital Stat Rep"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2133.1997.tb03654.x","article-title":"Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients","volume":"136","author":"Bernard","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0035","first-page":"751","article-title":"Survival prognosis in pemphigoid: A cohort analysis of 78 patients","volume":"122","author":"Bernard","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/ajrccm.154.3.8810595","article-title":"Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals","volume":"154","author":"Brun-Buisson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","article-title":"Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid","volume":"120","author":"Dimson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordon","year":"1967","journal-title":"J Am Med Assoc"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0070","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0075","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0080","first-page":"1137","article-title":"Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy","volume":"134","author":"Korman","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0085","series-title":"Sepsis and Septic Shock. Harrison's Principles of Internal Medicine","author":"Munford","year":"2001"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0095","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jama.1997.03550030074038","article-title":"Epidemiology of sepsis syndrome in 8 academic medical centers","volume":"278","author":"Sands","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0105","first-page":"195","article-title":"Septicemia in the elderly: Incidence, etiology and prognostic factors","volume":"26","author":"Sonnenblick","year":"1990","journal-title":"Isr J Med Sci"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"10.1111\/j.0022-202X.2004.22504.x_bb0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:50:21Z","timestamp":1682697021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15308083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022202X15308083"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.22504.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}